ArticleCureus2026
Prevalence of Vitamin B12 Deficiency Among Patients With Type 2 Diabetes Mellitus on Long-Term Metformin Therapy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitamin B12 insufficiency, which aggravates hematological and neurological problems in diabetics, has been linked to chronic metformin therapy, the main treatment for type 2 diabetes mellitus (T2DM). This study aimed to assess the prevalence of vitamin B12 deficiency in patients with T2DM on metformin and identify associated clinical and demographic factors in an Indian tertiary care setting. METHODOLOGY: An observational cross-sectional hospital-based study was conducted among adults with T2DM. Sociodemographic data, clinical history, diabetes duration, medication use, and laboratory parameters were recorded. Serum vitamin B12 levels were measured using standard laboratory cutoffs to identify deficiency, and data were analyzed using appropriate descriptive and inferential statistical methods.
resultsAmong 170 participants, multivariate logistic regression analysis identified metformin use for more than five years (adjusted odds ratio (OR): 2.85; 95% confidence interval (CI): 1.32-6.12), concomitant pantoprazole use (adjusted OR: 2.41; 95% CI: 1.08-5.34), and low high-density lipoprotein cholesterol levels below 40 mg/dL (adjusted OR: 2.22; 95% CI: 1.01-4.91) as independent predictors of vitamin B12 deficiency. Low hemoglobin levels, elevated low-density lipoprotein cholesterol levels, and poor glycemic control were not significantly associated (p > 0.05).
conclusionPatients with T2DM, especially those on long-term metformin medication, frequently lack vitamin B12. Timely supplementation and routine screening might help lower avoidable consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.